Protocol Ledger

NCT03378466 · Phase II · TERMINATED

Heparin Anticoagulation in Septic Shock

Interventional Phase II clinical trial protocol NCT03378466 sponsored by University of Manitoba in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-03-12 Enrollment: 178 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03378466
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)178 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03378466
Protocol FieldVerified Registry Value
NCT IdentifierNCT03378466
Consolidated Lead SponsorUniversity of Manitoba
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment178 participants (ACTUAL)
Registered Start Date2018-03-12
WhyStopped ClassificationInsufficient / Slow Accrual

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03378466
Hospital Research SiteLocationSite Profile
Hospital de Clínicas de Porto AlegrePorto Alegre, BrazilOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI